TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7759725
log Bayes Factor = <0.0001
Chromosome 6   position 11,655,970  (GRCh37) Explore rs7759725 on Ensembl!
Variant rs7759725 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D36.1 Peripheral nerves and autonomic nervous system
0.000 0.976 0.024
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.980 0.020
Y42.7 Androgens and anabolic congeners
0.019 0.981 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.981 0.019
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.981 0.019
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.981 0.019
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.982 0.018
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.982 0.018
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.983 0.017
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.983 0.017
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.983 0.017
T45.5 Anticoagulants
0.000 0.983 0.017
F33.1 Recurrent depressive disorder, current episode moderate
0.000 0.985 0.015
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.985 0.015
T45.2 Vitamins, not elsewhere classified
0.000 0.985 0.015
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.986 0.014
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.986 0.014
T36 Poisoning by systemic antibiotics
0.000 0.986 0.014
T43.6 Psychostimulants with abuse potential
0.000 0.986 0.014
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.986 0.014
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.986 0.014
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.986 0.014
T46.7 Peripheral vasodilators
0.000 0.986 0.014
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.986 0.014
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.986 0.014
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.986 0.013
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.986 0.013
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.986 0.013
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.986 0.013
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.986 0.013
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.986 0.013
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.986 0.013
T44.0 Anticholinesterase agents
0.000 0.986 0.013
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.986 0.013
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.987 0.013
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.987 0.013
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.987 0.013
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.987 0.013
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.987 0.013
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.987 0.013
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.987 0.013
T46.1 Calcium-channel blockers
0.000 0.987 0.013
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.987 0.013
T45.8 Other primarily systemic and haematological agents
0.000 0.987 0.013
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.987 0.013
T45.6 Fibrinolysis-affecting drugs
0.000 0.987 0.013
T45.4 Iron and its compounds
0.000 0.987 0.013
T45.3 Enzymes, not elsewhere classified
0.000 0.987 0.013
T43.9 Psychotropic drug, unspecified
0.000 0.987 0.013
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.987 0.013
T45.0 Antiallergic and antiemetic drugs
0.000 0.988 0.012
F33 Recurrent depressive disorder
0.000 0.988 0.012
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.988 0.011
F33.9 Recurrent depressive disorder, unspecified
0.000 0.989 0.011
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.989 0.011
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.989 0.011
T36.0 Penicillins
0.000 0.989 0.011
T50.8 Diagnostic agents
0.000 0.989 0.011
T50.7 Analeptics and opioid receptor antagonists
0.000 0.989 0.011
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.989 0.011
T50.5 Appetite depressants
0.000 0.989 0.011
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.989 0.011
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.989 0.011
T50.1 Loop [high-ceiling] diuretics
0.000 0.989 0.011
T50.0 Mineralocorticoids and their antagonists
0.000 0.989 0.011
T50.4 Drugs affecting uric acid metabolism
0.000 0.989 0.010
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.990 0.010
T36.9 Systemic antibiotic, unspecified
0.000 0.990 0.010
T36.8 Other systemic antibiotics
0.000 0.990 0.010
T36.7 Antifungal antibiotics, systemically used
0.000 0.990 0.010
T36.6 Rifamycins
0.000 0.990 0.010
T36.5 Aminoglycosides
0.000 0.990 0.010
T36.4 Tetracyclines
0.000 0.990 0.010
T36.3 Macrolides
0.000 0.990 0.010
T36.2 Chloramphenicol group
0.000 0.990 0.010
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.990 0.010
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.990 0.010
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.990 0.010
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.990 0.010
T37.5 Antiviral drugs
0.000 0.990 0.010
T37.4 Anthelminthics
0.000 0.990 0.010
T37.3 Other antiprotozoal drugs
0.000 0.990 0.010
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.990 0.010
T37.1 Antimycobacterial drugs
0.000 0.990 0.010
T37.0 Sulphonamides
0.000 0.990 0.010
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.010 0.990 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.990 0.010
T41.5 Therapeutic gases
0.000 0.990 0.009
T41.4 Anaesthetic, unspecified
0.000 0.990 0.009
T41.3 Local anaesthetics
0.000 0.990 0.009
T41.2 Other and unspecified general anaesthetics
0.000 0.990 0.009
T41.1 Intravenous anaesthetics
0.000 0.990 0.009
T41.0 Inhaled anaesthetics
0.000 0.990 0.009
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.990 0.009
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.990 0.009
T48.5 Anti-common-cold drugs
0.000 0.990 0.009
T48.4 Expectorants
0.000 0.990 0.009
T48.3 Antitussives
0.000 0.990 0.009
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.990 0.009
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.990 0.009
T48.0 Oxytocic drugs
0.000 0.990 0.009
T49.9 Topical agent, unspecified
0.000 0.990 0.009
T49.8 Other topical agents
0.000 0.990 0.009
T49.7 Dental drugs, topically applied
0.000 0.990 0.009
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.990 0.009
T49.5 Ophthalmological drugs and preparations
0.000 0.990 0.009
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.990 0.009
T49.3 Emollients, demulcents and protectants
0.000 0.990 0.009
T49.2 Local astringents and local detergents
0.000 0.990 0.009
T49.1 Antipruritics
0.000 0.990 0.009
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.990 0.009
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.990 0.009
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.990 0.009
T47.7 Emetics
0.000 0.990 0.009
T47.6 Antidiarrhoeal drugs
0.000 0.990 0.009
T47.5 Digestants
0.000 0.990 0.009
T47.4 Other laxatives
0.000 0.990 0.009
T47.3 Saline and osmotic laxatives
0.000 0.990 0.009
T47.2 Stimulant laxatives
0.000 0.990 0.009
T47.0 Histamine H(2)-receptor antagonists
0.000 0.990 0.009
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.990 0.009
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.991 0.009
T92.1 Sequelae of fracture of arm
0.000 0.991 0.009
F33.8 Other recurrent depressive disorders
0.000 0.991 0.008
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.991 0.008
Q21.1 Atrial septal defect
0.000 0.991 0.009
Y42.2 Antithyroid drugs
0.008 0.992 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.992 0.008
T39.4 Antirheumatics, not elsewhere classified
0.000 0.992 0.007
T39.2 Pyrazolone derivatives
0.000 0.992 0.007
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.001 0.993 0.006
Y42.1 Thyroid hormones and substitutes
0.007 0.993 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.993 0.007
Y42.9 Other and unspecified hormone antagonists
0.007 0.993 0.000
Y42.4 Oral contraceptives
0.007 0.993 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.993 0.007
Y52 Agents primarily affecting the cardiovascular system
0.007 0.993 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.007 0.993 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.007 0.993 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.007 0.993 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.007 0.993 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.007 0.993 0.000
T39.0 Salicylates
0.000 0.993 0.007
Y44 Agents primarily affecting blood constituents
0.007 0.993 0.000
Y52.1 Calcium-channel blockers
0.007 0.993 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.006 0.994 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.006 0.994 0.000
Z11.0 Special screening examination for intestinal infectious diseases
0.000 0.994 0.006
T40.4 Other synthetic narcotics
0.000 0.994 0.006
D36 Benign neoplasm of other and unspecified sites
0.000 0.994 0.006
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.994 0.006
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.006 0.994 0.000
Y44.2 Anticoagulants
0.006 0.994 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.994 0.006
T40.8 Lysergide [LSD]
0.000 0.994 0.006
T40.7 Cannabis (derivatives)
0.000 0.994 0.006
T40.5 Cocaine
0.000 0.994 0.006
T40.3 Methadone
0.000 0.994 0.006
T40.1 Heroin
0.000 0.994 0.006
T40.0 Opium
0.000 0.994 0.006
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.006 0.994 0.000
Y44.5 Thrombolytic drugs
0.006 0.994 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.994 0.006
Y59 Other and unspecified vaccines and biological substances
0.006 0.994 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.006 0.994 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.006 0.994 0.000
T38.9 Other and unspecified hormone antagonists
0.001 0.994 0.005
T38.8 Other and unspecified hormones and their synthetic substitutes
0.001 0.994 0.005
T38.7 Androgens and anabolic congeners
0.001 0.994 0.005
T38.5 Other oestrogens and progestogens
0.001 0.994 0.005
T38.4 Oral contraceptives
0.001 0.994 0.005
T38.2 Antithyroid drugs
0.001 0.994 0.005
T38.0 Glucocorticoids and synthetic analogues
0.001 0.994 0.005
T43.2 Other and unspecified antidepressants
0.000 0.994 0.006
Y58 Bacterial vaccines
0.006 0.994 0.000
T42.1 Iminostilbenes
0.000 0.994 0.005
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.994 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.995 0.005
T42.3 Barbiturates
0.000 0.995 0.005
T42.2 Succinimides and oxazolidinediones
0.000 0.995 0.005
Y53 Agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.005 0.995 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.005 0.995 0.000
Y52.7 Peripheral vasodilators
0.005 0.995 0.000
Y54.3 Benzothiadiazine derivatives
0.005 0.995 0.000
Z11 Special screening examination for infectious and parasitic diseases
0.000 0.995 0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.001 0.995 0.004
Z11.5 Special screening examination for other viral diseases
0.000 0.995 0.005
Y55.4 Expectorants
0.005 0.995 0.000
T40.6 Other and unspecified narcotics
0.000 0.995 0.005
Y40 Systemic antibiotics
0.005 0.995 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.005 0.995 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.005 0.995 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.005 0.995 0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]
0.000 0.995 0.005
Y46.6 Other and unspecified antiepileptics
0.005 0.995 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.005 0.995 0.000
Y44.7 Plasma substitutes
0.005 0.995 0.000
Y44.6 Natural blood and blood products
0.005 0.995 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.995 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.005 0.995 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.005 0.995 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.005 0.995 0.000
Y54.8 Agents affecting uric acid metabolism
0.005 0.995 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.995 0.005
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
T42.0 Hydantoin derivatives
0.000 0.995 0.005
Y54.9 Mineral salts, not elsewhere classified
0.005 0.995 0.000
Y54.7 Agents affecting calcification
0.005 0.995 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.005 0.995 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.005 0.995 0.000
Y54.0 Mineralocorticoids
0.005 0.995 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.995 0.000
Y55.5 Anticommon cold drugs
0.005 0.995 0.000
Y55.3 Antitussives
0.005 0.995 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.005 0.995 0.000
Y55.0 Oxytocic drugs
0.005 0.995 0.000
H43.8 Other disorders of vitreous body
0.000 0.995 0.005
T38.1 Thyroid hormones and substitutes
0.001 0.995 0.004
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
Y54.4 Loop [high-ceiling] diuretics
0.005 0.995 0.000
Y59.3 Immunoglobulin
0.005 0.995 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.995 0.000
Z11.2 Special screening examination for other bacterial diseases
0.000 0.995 0.005
Y41 Other systemic anti-infectives and antiparasitics
0.005 0.995 0.000
D36.9 Benign neoplasm of unspecified site
0.000 0.995 0.005
Y58.0 BCG vaccine
0.005 0.995 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.004 0.995 0.000
Y46.2 Hydantoin derivatives
0.004 0.995 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.004 0.995 0.000
Y40.4 Tetracyclines
0.004 0.995 0.000
Y40.6 Rifamycins
0.004 0.995 0.000
Y40.5 Aminoglycosides
0.004 0.996 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.004 0.996 0.000
D36.0 Lymph nodes
0.000 0.996 0.004
Y54.5 Other diuretics
0.004 0.996 0.000
Y57.6 Other diagnostic agents
0.004 0.996 0.000
Y59.9 Vaccine or biological substance, unspecified
0.004 0.996 0.000
Y59.8 Other specified vaccines and biological substances
0.004 0.996 0.000
Y59.2 Protozoal vaccines
0.004 0.996 0.000
Y59.1 Rickettsial vaccines
0.004 0.996 0.000
Y59.0 Viral vaccines
0.004 0.996 0.000
Y46.8 Antispasticity drugs
0.004 0.996 0.000
Y46.7 Anti-Parkinsonism drugs
0.004 0.996 0.000
Y46.5 Valproic acid
0.004 0.996 0.000
Y46.3 Deoxybarbiturates
0.004 0.996 0.000
Y46.1 Oxazolidinediones
0.004 0.996 0.000
Y46.0 Succinimides
0.004 0.996 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.996 0.004
Y58.9 Other and unspecified bacterial vaccines
0.004 0.996 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.004 0.996 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.004 0.996 0.000
Y58.5 Diphtheria vaccine
0.004 0.996 0.000
Y58.4 Tetanus vaccine
0.004 0.996 0.000
Y58.3 Plague vaccine
0.004 0.996 0.000
Y58.2 Cholera vaccine
0.004 0.996 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.004 0.996 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.004 0.996 0.000
Y53.7 Emetics
0.004 0.996 0.000
Y53.6 Antidiarrhoeal drugs
0.004 0.996 0.000
Y53.5 Digestants
0.004 0.996 0.000
Y53.3 Saline and osmotic laxatives
0.004 0.996 0.000
Y53.2 Stimulant laxatives
0.004 0.996 0.000
Y53.0 Histamine H2-receptor antagonists
0.004 0.996 0.000
Z11.8 Special screening examination for other infectious and parasitic diseases
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.996 0.004
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission
0.000 0.996 0.004
S61.1 Open wound of finger(s) with damage to nail
0.000 0.996 0.004
Y40.7 Antifungal antibiotics, systemically used
0.004 0.996 0.000
Y40.2 Chloramphenicol group
0.004 0.996 0.000
Y50.9 Central nervous system stimulant, unspecified
0.004 0.996 0.000
Y50.8 Other central nervous system stimulants
0.004 0.996 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.004 0.996 0.000
Y50.1 Opioid receptor antagonists
0.004 0.996 0.000
Y50.0 Analeptics
0.004 0.996 0.000
Y53.4 Other laxatives
0.004 0.996 0.000
Y56.9 Topical agent, unspecified
0.004 0.996 0.000
Y56.8 Other topical agents
0.004 0.996 0.000
Y56.7 Dental drugs, topically applied
0.004 0.996 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.004 0.996 0.000
Y56.5 Ophthalmological drugs and preparations
0.004 0.996 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.004 0.996 0.000
Y56.3 Emollients, demulcents and protectants
0.004 0.996 0.000
Y56.2 Local astringents and local detergents
0.004 0.996 0.000
Y56.1 Antipruritics
0.004 0.996 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.004 0.996 0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases
0.000 0.996 0.004
N80.3 Endometriosis of pelvic peritoneum
0.004 0.996 0.000
Z11.1 Special screening examination for respiratory tuberculosis
0.000 0.996 0.004
H44.2 Degenerative myopia
0.000 0.996 0.004
H49.2 Sixth [abducent] nerve palsy
0.004 0.996 0.000
Y41.5 Antiviral drugs
0.004 0.996 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.004 0.996 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.004 0.996 0.000
Y47.4 Bromine compounds
0.004 0.996 0.000
Y47.3 Paraldehyde
0.004 0.996 0.000
Y47.2 Chloral derivatives
0.004 0.996 0.000
Y47.0 Barbiturates, not elsewhere classified
0.004 0.996 0.000
Q21 Congenital malformations of cardiac septa
0.000 0.996 0.004
Y57.7 Vitamins, not elsewhere classified
0.004 0.996 0.000
Y57.4 Pharmaceutical excipients
0.004 0.996 0.000
Y57.3 Alcohol deterrents
0.004 0.996 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.004 0.996 0.000
Y57.1 Lipotropic drugs
0.004 0.996 0.000
Y57.0 Appetite depressants [anorectics]
0.004 0.996 0.000
Y41.1 Antimycobacterial drugs
0.004 0.996 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
H43 Disorders of vitreous body
0.000 0.996 0.004
C90.2 Plasmacytoma, extramedullary
0.004 0.996 0.000
H44 Disorders of globe
0.000 0.996 0.004
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.004 0.996 0.000
Y41.4 Anthelminthics
0.004 0.996 0.000
Y41.3 Other antiprotozoal drugs
0.004 0.996 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.004 0.996 0.000
Y57.5 X-ray contrast media
0.004 0.996 0.000
Y43 Primarily systemic agents
0.004 0.996 0.000
S61.9 Open wound of wrist and hand, part unspecified
0.004 0.996 0.000
Y40.3 Macrolides
0.004 0.996 0.000
H43.9 Disorder of vitreous body, unspecified
0.000 0.996 0.004
T42.4 Benzodiazepines
0.000 0.996 0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.002 0.996 0.002
Y47.1 Benzodiazepines
0.003 0.996 0.000
C90.0 Multiple myeloma
0.004 0.996 0.000
H44.1 Other endophthalmitis
0.000 0.997 0.003
H49.9 Paralytic strabismus, unspecified
0.003 0.997 0.000
Y46.4 Iminostilbenes
0.003 0.997 0.000
Y40.8 Other systemic antibiotics
0.003 0.997 0.000
D36.7 Other specified sites
0.000 0.997 0.003
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.003 0.997 0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified
0.000 0.997 0.003
Y41.0 Sulphonamides
0.003 0.997 0.000
Y57.8 Other drugs and medicaments
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
Y48 Anaesthetics and therapeutic gases
0.003 0.997 0.000
T39.1 4-Aminophenol derivatives
0.000 0.997 0.003
Z90.1 Acquired absence of breast(s)
0.000 0.997 0.003
Y43.1 Antineoplastic antimetabolites
0.003 0.997 0.000
L90.5 Scar conditions and fibrosis of skin
0.000 0.997 0.003
H43.2 Crystalline deposits in vitreous body
0.000 0.997 0.003
N18.4 Chronic kidney disease, stage 4
0.003 0.997 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.003 0.997 0.000
H44.4 Hypotony of eye
0.000 0.997 0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.003 0.997 0.000
Y57.9 Drug or medicament, unspecified
0.003 0.997 0.000
H49 Paralytic strabismus
0.003 0.997 0.000
Q21.0 Ventricular septal defect
0.000 0.997 0.003
C90 Multiple myeloma and malignant plasma cell neoplasms
0.003 0.997 0.000
Q21.3 Tetralogy of Fallot
0.000 0.997 0.003
Y42.5 Other oestrogens and progestogens
0.003 0.997 0.000
Y40.9 Systemic antibiotic, unspecified
0.003 0.997 0.000
Y40.0 Penicillins
0.003 0.997 0.000
H43-H45 Disorders of vitreous body and globe
0.000 0.997 0.003
H44.0 Purulent endophthalmitis
0.000 0.997 0.003
Q21.8 Other congenital malformations of cardiac septa
0.000 0.997 0.003
Q21.4 Aortopulmonary septal defect
0.000 0.997 0.003
Q21.2 Atrioventricular septal defect
0.000 0.997 0.003
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.003 0.997 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.003 0.997 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.003 0.997 0.000
Y51.0 Anticholinesterase agents
0.003 0.997 0.000
H44.9 Disorder of globe, unspecified
0.000 0.997 0.003
H44.7 Retained (old) intraocular foreign body, nonmagnetic
0.000 0.997 0.003
H44.6 Retained (old) intraocular foreign body, magnetic
0.000 0.997 0.003
H44.5 Degenerated conditions of globe
0.000 0.997 0.003
H44.3 Other degenerative disorders of globe
0.000 0.997 0.003
Y43.9 Primarily systemic agent, unspecified
0.003 0.997 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.003 0.997 0.000
Y43.6 Enzymes, not elsewhere classified
0.003 0.997 0.000
Y43.5 Acidifying and alkalising agents
0.003 0.997 0.000
Y43.2 Antineoplastic natural products
0.003 0.997 0.000
Z39.1 Care and examination of lactating mother
0.003 0.997 0.000
H43.3 Other vitreous opacities
0.000 0.997 0.003
Z54.0 Convalescence following surgery
0.000 0.997 0.003
I49.8 Other specified cardiac arrhythmias
0.003 0.997 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.003 0.997 0.000
Y43.0 Antiallergic and antiemetic drugs
0.003 0.997 0.000
H43.0 Vitreous prolapse
0.000 0.997 0.003
H49.0 Third [oculomotor] nerve palsy
0.003 0.997 0.000
Q07.0 Arnold-Chiari syndrome
0.003 0.997 0.000
N18.9 Chronic renal failure, unspecified
0.003 0.997 0.000
Y48.5 Therapeutic gases
0.002 0.997 0.000
Y48.1 Parenteral anaesthetics
0.002 0.997 0.000
Y48.0 Inhaled anaesthetics
0.002 0.997 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.997 0.000
H44.8 Other disorders of globe
0.000 0.997 0.002
T40.2 Other opioids
0.000 0.997 0.003
Y43.4 Immunosuppressive agents
0.003 0.997 0.000
C90.1 Plasma cell leukaemia
0.002 0.997 0.000
H49.8 Other paralytic strabismus
0.002 0.997 0.000
H49.4 Progressive external ophthalmoplegia
0.002 0.997 0.000
H49.3 Total (external) ophthalmoplegia
0.002 0.997 0.000
N18.0 End-stage renal disease
0.002 0.997 0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.997 0.002
J93.9 Pneumothorax, unspecified
0.000 0.998 0.002
D23.1 Skin of eyelid, including canthus
0.002 0.998 0.000
H49.1 Fourth [trochlear] nerve palsy
0.002 0.998 0.000
Q21.9 Congenital malformation of cardiac septum, unspecified
0.000 0.998 0.002
X49.9 Unspecified place
0.000 0.998 0.002
R47.8 Other and unspecified speech disturbances
0.000 0.998 0.002
Y49.0 Tricyclic and tetracyclic antidepressants
0.002 0.998 0.000
Y48.3 Local anaesthetics
0.002 0.998 0.000
S32.00 Fracture of lumbar vertebra (closed)
0.002 0.998 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
M89.04 Algoneurodystrophy (Hand)
0.000 0.998 0.002
S09.9 Unspecified injury of head
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
C83.3 Large cell (diffuse)
0.002 0.998 0.000
J93.1 Other spontaneous pneumothorax
0.000 0.998 0.002
I60.9 Subarachnoid haemorrhage, unspecified
0.002 0.998 0.000
Y48.4 Anaesthetic, unspecified
0.002 0.998 0.001
C90.3 Solitary plasmacytoma
0.002 0.998 0.000
M89.0 Algoneurodystrophy
0.000 0.998 0.002
M89.07 Algoneurodystrophy (Ankle and foot)
0.000 0.998 0.002
S27.3 Other injuries of lung
0.002 0.998 0.000
Y48.2 Other and unspecified general anaesthetics
0.002 0.998 0.001
O75.8 Other specified complications of labour and delivery
0.000 0.998 0.002
M94.26 Chondromalacia (Lower leg)
0.002 0.998 0.000
D10.1 Tongue
0.002 0.998 0.000
N18 Chronic renal failure
0.002 0.998 0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.998 0.002
H45.1 Endophthalmitis in diseases classified elsewhere
0.000 0.998 0.002
H45.0 Vitreous haemorrhage in diseases classified elsewhere
0.000 0.998 0.002
Y45.1 Salicylates
0.002 0.998 0.000
M89.03 Algoneurodystrophy (Forearm)
0.000 0.998 0.002
M89.87 Other specified disorders of bone (Ankle and foot)
0.000 0.998 0.002
R22.9 Localised swelling, mass and lump, unspecified
0.002 0.998 0.000
E10.5 With peripheral circulatory complications
0.002 0.998 0.000
Y49.5 Other antipsychotics and neuroleptics
0.001 0.998 0.001
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
C83.5 Lymphoblastic (diffuse)
0.002 0.998 0.000
F60.3 Emotionally unstable personality disorder
0.000 0.998 0.002
Y45.4 Antirheumatics
0.002 0.998 0.000
Y45.2 Propionic acid derivatives
0.002 0.998 0.000
Y45.8 Other analgesics and antipyretics
0.002 0.998 0.000
Q07 Other congenital malformations of nervous system
0.002 0.998 0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)
0.000 0.998 0.002
H61.0 Perichondritis of external ear
0.002 0.998 0.000
M89.08 Algoneurodystrophy (Other)
0.000 0.998 0.002
M89.05 Algoneurodystrophy (Pelvic region and thigh)
0.000 0.998 0.002
M89.02 Algoneurodystrophy (Upper arm)
0.000 0.998 0.002
M89.01 Algoneurodystrophy (Shoulder region)
0.000 0.998 0.002
M89.00 Algoneurodystrophy (Multiple sites)
0.000 0.998 0.002
E87.6 Hypokalaemia
0.002 0.998 0.000
M89.06 Algoneurodystrophy (Lower leg)
0.000 0.998 0.002
C83 Diffuse non-Hodgkin's lymphoma
0.002 0.998 0.000
M89 Other disorders of bone
0.000 0.998 0.002
S27.31 Other injuries of lung (with open wound into thoracic cavity)
0.002 0.998 0.000
I97.1 Other functional disturbances following cardiac surgery
0.000 0.998 0.002
B99 Other and unspecified infectious diseases
0.002 0.998 0.000
M89.8 Other specified disorders of bone
0.000 0.998 0.002
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.002 0.998 0.000
M89.9 Disorder of bone, unspecified
0.000 0.998 0.002
M89.3 Hypertrophy of bone
0.000 0.998 0.002
N30.8 Other cystitis
0.002 0.998 0.000
C83.1 Small cleaved cell (diffuse)
0.002 0.998 0.000
E87.1 Hypo-osmolality and hyponatraemia
0.002 0.998 0.000
Y45.5 4-Aminophenol derivatives
0.002 0.998 0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.002 0.998 0.000
N18.2 Chronic kidney disease, stage 2
0.002 0.998 0.000
T51.9 Alcohol, unspecified
0.000 0.998 0.002
M89.86 Other specified disorders of bone (Lower leg)
0.000 0.998 0.002
I25.3 Aneurysm of heart
0.000 0.998 0.002
L53.0 Toxic erythema
0.002 0.998 0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)
0.002 0.998 0.000
C82.0 Small cleaved cell, follicular
0.002 0.998 0.000
K22.4 Dyskinesia of oesophagus
0.002 0.998 0.000
M89.84 Other specified disorders of bone (Hand)
0.000 0.998 0.002
M89.96 Disorder of bone, unspecified (Lower leg)
0.000 0.998 0.002
D10.5 Other parts of oropharynx
0.002 0.998 0.000
H61.1 Non-infective disorders of pinna
0.002 0.998 0.000
N18.1 Chronic kidney disease, stage 1
0.002 0.998 0.000
Q07.9 Congenital malformation of nervous system, unspecified
0.001 0.998 0.000
Q07.8 Other specified congenital malformations of nervous system
0.001 0.998 0.000
M89.37 Hypertrophy of bone (Ankle and foot)
0.000 0.998 0.002
S72.40 Fracture of lower end of femur (closed)
0.002 0.998 0.000
M89.38 Hypertrophy of bone (Other)
0.000 0.998 0.001
M89.94 Disorder of bone, unspecified (Hand)
0.000 0.998 0.002
C83.7 Burkitt's tumour
0.002 0.998 0.000
K60.1 Chronic anal fissure
0.002 0.998 0.000
M89.5 Osteolysis
0.000 0.998 0.002
C83.6 Undifferentiated (diffuse)
0.001 0.998 0.000
C83.4 Immunoblastic (diffuse)
0.001 0.998 0.000
C83.2 Mixed small and large cell (diffuse)
0.001 0.998 0.000
E10.4 With neurological complications
0.002 0.998 0.000
F60.9 Personality disorder, unspecified
0.000 0.998 0.002
H43.1 Vitreous haemorrhage
0.000 0.998 0.002
L53.8 Other specified erythematous conditions
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.